Mitochondrial and inflammatory changes in sporadic inclusion body myositis
Article first published online: 4 MAR 2015
© 2014 The Authors. Neuropathology and Applied Neurobiology published by John Wiley & Sons Ltd on behalf of British Neuropathological Society.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Neuropathology and Applied Neurobiology
Volume 41, Issue 3, pages 288–303, April 2015
How to Cite
Rygiel, K. A., Miller, J., Grady, J. P., Rocha, M. C., Taylor, R. W. and Turnbull, D. M. (2015), Mitochondrial and inflammatory changes in sporadic inclusion body myositis. Neuropathology and Applied Neurobiology, 41: 288–303. doi: 10.1111/nan.12149
- Issue published online: 4 MAR 2015
- Article first published online: 4 MAR 2015
- Accepted manuscript online: 18 APR 2014 03:14AM EST
- Manuscript Accepted: 24 MAR 2014
- Manuscript Received: 13 DEC 2013
- Newcastle University Centre for Brain Ageing and Vitality
- Biotechnology and Biological Sciences Research Council
- Engineering and Physical Sciences Research Council
- Economic and Social Research Council
- Medical Research Council. Grant Number: G0700718
- UK NIHR Biomedical Research Centre in Age and Age Related Diseases
- Newcastle upon Tyne Hospitals NHS Foundation Trust
- MRC Centre for Neuromuscular Disease. Grant Number: G000608-1
- The Wellcome Trust Centre for Mitochondrial Research. Grant Number: 096919/Z/11/Z
- The Lily Foundation
- UK NHS Highly Specialised ‘Rare Mitochondrial Disorders of Adults and Children’ Service
Figure S1. We hypothesize that the long-term inflammation in sIBM is a key trigger to the mtDNA damage, leading to the accumulation of clonally expanded mtDNA deletions. Mitochondrial DNA mutations may form as a result of inflammatory insult such as RONS (reactive oxygen and nitrogen species) or inflammatory cytokines present in the environment. Mitochondrial mutations accumulated above a critical threshold can cause a phenotypic effect such as muscle atrophy, splitting and breakage (Bua et al. 2002), explaining the correlation of respiratory deficiency with muscle atrophy. As sIBM is considered an autoimmune disease we may speculate that an initial viral infection triggers breakage of immune tolerance mediated by CD8-positive T cells and causes an autoimmune response. Secretion of inflammatory cytokines results in upregulation of MHC I and the co-stimulatory molecules by muscle fibres, which then become a target for an immune attack. The inflammatory environment may directly cause double-strand breaks in mtDNA (dsDNA breaks). Alternatively, MHC I upregulation may cause ER stress response which leads to accumulation of misfolded toxic proteins such as β-amyloid. The latter augments inflammatory reaction and associates with mitochondrial membranes disrupting intramitochondrial processes. Faulty repair mechanisms subsequently lead to the accumulation of damaged mtDNA molecules in the cell causing respiratory deficiency (Krishnan et al. 2008).
Table S1. Clinical data of cases analysed in the study.
Table S2. Description and source of the antibodies used for IHC assessments.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.